Delivery Order SPE2DB22D3301-SPE2DB25FZ0AK
- Not listed
- The Defense Logistics Agency awarded a $3,193.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.86 to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Brimonidine Tartrate 0.15% ophthalmic drops in 10ml units. This is a firm fixed price contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of June 6, 2025. The award represents a competitive procurement under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 10 milliliters of Brimonidine Tartrate 0.15% ophthalmic drops, valued at $1,213.60, with a completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger indefinite delivery contract (IDC) vehicle that...
- The Defense Logistics Agency awarded a $1,960.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.1% ophthalmic drops (5mL) with an ultimate completion date of July 31, 2025. This delivery order, issued on July 30, 2025, is classified as a child contract and was awarded without a set-aside designation through competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Brimonidine...
- The Defense Logistics Agency awarded a delivery order valued at $4,256.19 to AmerisourceBergen Drug Corp for the supply of Brimonidine-Timolol 0.2%-0.5% ophthalmic solution in a 10 milliliter formulation, with completion expected by August 29, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,145.90 to AmerisourceBergen Drug Corp for Brimonidine-Timolol 0.2%-0.5% ophthalmic solution (10ml), with an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical supply requirements. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,439.96 firm fixed-price contract is for the supply of 4566932081 - Brimonidine Tartrate 0.15% Ophthalmic Drops, 10 mL. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
- The Defense Logistics Agency awarded a $1,470 delivery order to Amerisourcebergen Drug Corporation for brimonidine 0.2% eye drops. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the ophthalmic solution to support DLA programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in late September 2023. The firm fixed price contract utilizes no set-aside designations and is issued against an existing DLA-wide supply...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,956,051 units of Brimonidine Tartrate 0.15% eye drop solution in 10 mL bottles. The $1,557.50 contract has a performance period through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor, providing pharmaceutical and medical supply distribution services to the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 delivery order contract is for the supply of brimonidine tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price (FFP) delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0AKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,237.09 to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (15mL) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle (SPE2DX) that runs through December 2026 and enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant portfolio of federal medical procurement contracts with the Defense Logistics Agency, supplying an extensive range of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's consistent competitively-awarded delivery orders demonstrate its capability to meet federal procurement requirements and serve critical customers including the Defense Health Agency and U.S. Coast Guard. This particular delivery order for ophthalmic medication represents routine pharmaceutical supply fulfillment under the company's comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/26/25 |